Absorption, metabolism and excretion of di(rho-aminophenyl) sulphone (dapsone) and di(rho-aminophenyl) sulphoxide in man.
作者信息
Ellard G A
出版信息
Br J Pharmacol Chemother. 1966 Jan;26(1):212-7. doi: 10.1111/j.1476-5381.1966.tb01823.x.
Abstract
摘要
相似文献
1
Absorption, metabolism and excretion of di(rho-aminophenyl) sulphone (dapsone) and di(rho-aminophenyl) sulphoxide in man.
Br J Pharmacol Chemother. 1966 Jan;26(1):212-7. doi: 10.1111/j.1476-5381.1966.tb01823.x.
2
Metabolism and excretion of di(p-aminophenyl) sulphoxide in different animal species.
Br J Pharmacol Chemother. 1960 Mar;15(1):160-4. doi: 10.1111/j.1476-5381.1960.tb01225.x.
3
Weekly self-medication of leprosy patients monitored by DDS/creatinine ratios in urines.
Lepr Rev. 1976 Sep;47(3):201-9. doi: 10.5935/0305-7518.19760031.
4
Urinary excretory pattern of DDS in leprosy patients.
Lepr Rev. 1968 Apr;39(2):87-90. doi: 10.5935/0305-7518.19680017.
5
Application of HI test for dapsone in urine under field conditions.
Indian J Lepr. 1985 Apr-Jun;57(2):318-22.
6
7
Dapsone drug compliance study among leprosy patients: a comparison between qualitative and quantitative methods.
Indian J Lepr. 1989 Jul;61(3):373-8.
8
Influence of rifampicin on D.D.S. excretion in urine.
Lepr India. 1979 Jan;51(1):54-9.
9
Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
Lepr India. 1981 Jan;53(1):17-22.
10
Comparative value of Dapsone "spot test" and Dapsone "tile test" in leprosy control programme.
Indian J Lepr. 1984 Oct-Dec;56(4):847-51.
引用本文的文献
1
Dapsone-Induced Hypoxia.
Cureus. 2020 Jul 22;12(7):e9334. doi: 10.7759/cureus.9334.
2
Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.
PLoS One. 2014 Jan 22;9(1):e85712. doi: 10.1371/journal.pone.0085712. eCollection 2014.
3
Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.
Eur J Clin Pharmacol. 1980 Feb;17(2):129-33. doi: 10.1007/BF00562621.
4
A rapid method for determination of acetylation phenotype using dapsone.
Br J Clin Pharmacol. 1984 Apr;17(4):465-9. doi: 10.1111/j.1365-2125.1984.tb02373.x.
5
N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.
Naunyn Schmiedebergs Arch Pharmacol. 1973;278(1):55-68. doi: 10.1007/BF00501863.
6
Clinical pharmacokinetics of dapsone.
Clin Pharmacokinet. 1986 Jul-Aug;11(4):299-315. doi: 10.2165/00003088-198611040-00003.
7
Clinical pharmacokinetic considerations in the treatment of patients with leprosy.
Clin Pharmacokinet. 1989 Jun;16(6):365-86. doi: 10.2165/00003088-198916060-00003.
8
Acetylation polymorphism and leprosy.
Biochem Genet. 1990 Feb;28(1-2):1-7. doi: 10.1007/BF00554816.
9
The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Br J Clin Pharmacol. 1992 Sep;34(3):244-9. doi: 10.1111/j.1365-2125.1992.tb04131.x.
10
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.
Br J Clin Pharmacol. 1978 Nov;6(5):421-7. doi: 10.1111/j.1365-2125.1978.tb04606.x.
本文引用的文献
1
The action of substances allied to 4:4'-diaminodiphenylsulphone in streptococcal and other infections in mice.
Biochem J. 1938 Jul;32(7):1101-10. doi: 10.1042/bj0321101.
2
[Research on the mechanism of action of sulfones; II.--Analytic study].
Ann Inst Pasteur (Paris). 1950 Jan;78(1):140-3.
3
The pharmacology of the sulfones.
Ann N Y Acad Sci. 1949 Dec 14;52(5):719-28. doi: 10.1111/j.1749-6632.1949.tb53962.x.
4
Studies in sulphone therapy.
Lepr Rev. 1952 Jan;23(1):4-29. doi: 10.5935/0305-7518.19520002.
5
Metabolism and excretion of di(p-aminophenyl) sulphoxide in different animal species.
Br J Pharmacol Chemother. 1960 Mar;15(1):160-4. doi: 10.1111/j.1476-5381.1960.tb01225.x.
6
Excretion products of 4:4'-diaminodiphenyl sulfone.
Am Rev Tuberc. 1955 Jul;72(1):123-5. doi: 10.1164/artpd.1955.72.1.123.
7
The chemotherapy of leprosy.
Pharmacol Rev. 1958 Mar;10(1):1-42.
8
[4, 4'-Diaminodiphenylsulfoxide in the treatment of leprosy].
Bull Acad Natl Med. 1957;141(9-10):195-204.
9
The treatment of leprosy with diaminodiphenyl sulphoxide: a progress report.
Lepr Rev. 1957 Apr;28(2):51-9. doi: 10.5935/0305-7518.19570006.
10
Radioactive tracer studies on uptake of di-amino-diphenyl-sulphone by leprosy patients.
Proc Soc Exp Biol Med. 1957 Jan;94(1):122-5. doi: 10.3181/00379727-94-22875.
Zotero 插件